A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs TPX 100 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors OrthoTrophix
- 18 Sep 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Oct 2017.
- 24 Jul 2017 Status changed from not yet recruiting to recruiting.
- 26 Apr 2017 New trial record